UNITY BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.5 USD | +1.35% |
|
0.00% | -22.28% |
Chart calendar Unity Biotechnology, Inc.
152712.5fy0bOnZxjd_BIcJXcGtlogd8PRG0ObZJULESiyxRPE.0pLmIa26sXYVdrBYFa_MpM9JgocX5rGtUwbpL3bXDoGJucQA3Y2UcR5Gvw~cc3438a9cbee4f2c59761f61585ff15a
Upcoming events on Unity Biotechnology, Inc.
Past events on Unity Biotechnology, Inc.
| 15/04/2024 12:00 | Q4 2023 Earnings Release |
| 14/11/2023 02:05 | Q3 2023 Earnings Release |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 16/08/2023 17:00 | H.C. Wainwright Ophthalmology Virtual Conference - Panel |
| 16/08/2023 12:00 | H.C. Wainwright Ophthalmology Virtual Conference |
| 08/08/2023 21:05 | Q2 2023 Earnings Release |
| 23/06/2023 17:00 | Annual General Meeting |
| 09/05/2023 21:05 | Q1 2023 Earnings Release |
| 24/04/2023 13:00 | UBX1325 Phase 2 Clinical Trial Results Call |
| 27/03/2023 13:00 | UBX1325 Phase 2 Study Results Call |
| 15/03/2023 20:05 | Q4 2022 Earnings Release |
| 07/03/2023 14:50 | Cowen Health Care Conference |
| 15/02/2023 16:20 | SVB Securities Global Biopharma Conference |
| 14/02/2023 15:00 | ENVISION Phase 2 Study Results Call |
| 08/11/2022 | Q3 2022 Earnings Release (Projected) |
| 01/11/2022 12:00 | UBX1325 Phase 2 Study Resluts Call |
| 17/10/2022 | Extraordinary Shareholders Meeting |
| 12/10/2022 13:00 | Analyst & Investor Day |
| 12/09/2022 21:00 | H.C. Wainwright Global Investment Conference |
| 05/09/2022 | Citi BioPharma Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 4,78 0,00 - | 0,24 0,23 3.96% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -87,0 -85,8 -1.42% | -90,5 -95,0 4.78% | -53,8 -60,3 10.84% | -55,4 -54,7 -1.25% | 0,00 -39,8 - | -40,1 |
|
EBIT Million USD | Released Forecast Spread | -89,7 -88,7 -1.08% | -93,9 -103 9.02% | -56,7 -65,9 14.05% | -57,6 -57,5 -0.18% | -44,7 -46,4 3.74% | -35,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -60,7 -71,4 14.99% | -59,9 -60,4 0.8% | -39,9 -50,1 20.47% | -41,2 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -60,7 -70,1 13.41% | -59,9 -60,6 1.05% | -39,9 -50,1 20.39% | -41,2 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -10,9 -12,8 14.62% | -6,31 -2,90 -117.34% | -2,70 -3,43 21.17% | -2,42 |
| Announcement Date | 11/03/20 | 23/03/21 | 15/03/22 | 15/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,78 0,00 - | 0,00 0,00 - | 0,24 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -8,83 | -9,28 | -9,76 | -10,3 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -9,90 -19,8 50.06% | -18,3 -15,1 -20.97% | -12,3 -17,7 30.55% | -13,1 -13,1 -0.43% | -13,9 -13,9 0.1% | -10,7 -15,0 28.82% | -12,0 -12,0 -0.05% | -14,9 -12,7 -17.54% | -7,68 -10,7 28.4% | -9,38 | -9,85 | -10,3 | -10,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,7 -21,4 50.04% | -18,9 -17,1 -10.69% | -13,1 -18,1 27.39% | -13,7 -14,0 2.12% | -14,2 -14,6 2.97% | -10,9 -15,6 30.21% | -12,2 -12,6 3.46% | -15,3 -13,0 -17.74% | -4,34 -11,8 63.1% | -9,58 | -10,0 | -10,5 | -11,1 |
|
Net income Million USD | Released Forecast Spread | -10,7 -20,1 46.8% | -18,9 -17,1 -10.69% | -13,1 -18,4 28.56% | -13,7 -13,9 1.05% | -14,2 -14,6 3.16% | -10,9 -15,6 30.21% | -12,2 -12,2 0.31% | -15,3 -13,0 -17.74% | -4,34 -11,8 63.1% | -9,58 | -10,0 | -10,5 | -11,1 |
|
EPS USD | Released Forecast Spread | -1,80 -3,60 50% | -2,80 -2,67 -5% | -1,90 -2,93 35.04% | -1,36 -1,07 -27.7% | -1,00 -1,03 3.23% | -0,76 -1,09 30.06% | -0,85 -0,85 0% | -1,05 -0,89 -17.98% | -0,28 -0,77 63.64% | -0,57 | -0,59 | -0,62 | -0,64 |
| Announcement Date | 15/03/22 | 10/05/22 | 12/08/22 | 08/11/22 | 15/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 15/04/24 | - | - | - | - |
More events
Past sector events for Unity Biotechnology, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- UBX Stock
- Calendar Unity Biotechnology, Inc.
